ULBI Stock Risk & Deep Value Analysis

Ultralife Corp

DVR Score

0.4

out of 10

Distressed

What You Need to Know About ULBI Stock

We analyzed Ultralife Corp using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran ULBI through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.

Updated May 6, 2026Run Fresh Analysis →

ULBI Risk Analysis & Red Flags

What Could Go Wrong

The company's recent Q4 2025 earnings miss and negative net margin (-3.09%) suggest operational challenges. If this trend continues in Q1 2026, it could lead to further revenue deceleration and sustained losses, eroding its strong balance sheet over time and potentially requiring dilutive financing.

Risk Matrix

Overall

Moderate

Financial

Medium

Market

Low

Competitive

Medium

Execution

Medium

Regulatory

Low

Red Flags

  • Q4 2025 revenue ($48.48M) and EPS ($0.12) significantly missed analyst estimates ($57.0M and $0.24, respectively).

  • Reported negative net margin of -3.09% for Q4 2025.

  • No material growth catalysts or strategic pivots identified that could drive 10x growth.

  • Trailing P/E is negative (-19.06) due to losses.

Upcoming Risk Events

  • 📅

    Q1 2026 earnings miss on revenue or EPS estimates

  • 📅

    Continued negative net margins or cash flow burn

  • 📅

    Loss of significant existing contracts or key customers

When to Reconsider

  • 🚪

    Exit if Q1 2026 revenue misses estimates or if net margins remain negative.

  • 🚪

    Sell if debt-to-equity ratio significantly increases from the current 0.35 without clear growth drivers.

  • 🚪

    Any unexpected executive departures or major contract losses.

Unlock ULBI Risk Analysis & Red Flags

Create a free account to see the full analysis

Investment Thesis

Ultralife Corp is a small-cap niche player providing specialized batteries and communications systems primarily to defense and industrial markets. While it possesses a strong balance sheet and a narrow moat in its established segments, recent operational challenges (Q4 2025 earnings miss, negative net margin) make a 10x growth scenario highly improbable. Investment is speculative, betting on a turnaround to consistent profitability and modest growth within its niche, rather than disruptive expansion, making it unsuitable for high-risk, high-reward investors targeting 10x returns.

Is ULBI Stock Undervalued?

The previous score of 6/100 acknowledged Ultralife Corp's stability and niche competence but highlighted its lack of 10x growth attributes. The material changes since the last analysis, specifically the Q4 2025 earnings reported on March 10, 2026, show a miss on both revenue ($48.48M vs. $57.0M estimate) and EPS ($0.12 vs. $0.24 estimate), accompanied by a negative net margin (-3.09%). This represents a deterioration in recent financial performance and questions the previous assessment of fundamental stability, further diminishing any long-shot potential for exponential growth. While the balance sheet remains strong, the decline in profitability trajectory and missed expectations, without any new significant growth drivers, justifies a downward adjustment of 2 points to reflect the increased operational risk and reduced near-term optimism for a 10x return.

Unlock the full AI analysis for ULBI

Get the complete DVR score, risk analysis, and more

📈

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

ULBI Price Targets & Strategy

12-Month Target

$10.00

Bull Case

$12.50

Bear Case

$5.50

Valuation Basis

Return to modest profitability enabling a 0.75x-1.0x P/S multiple on projected ~$200M TTM revenue (assuming Q1 '26 guidance is met and prior quarters normalize).

Entry Strategy

Given impending Q1 earnings, consider dollar-cost averaging after the report, especially if the price dips towards $5.50-$6.00 (a potential support zone).

Exit Strategy

Take profit on any positive news or strong Q1 results pushing the stock towards $9.00-$10.00. Set a stop-loss order at $5.50 if Q1 earnings are weak or negative trends persist.

Portfolio Allocation

1-2% for aggressive risk tolerance, highly speculative due to limited 10x growth potential.

Price Targets & Strategy

Sign up free to unlock price targets and entry/exit strategies

Is ULBI Financially Healthy?

Valuation

P/E Ratio

-19.06

Price/Book

1.44

Price/Sales

0.59

Profitability

Gross Margin

24.07%

Operating Margin

-3.09%

Net Margin

-3.09%

Return on Equity

-4.35%

Revenue Growth

16.24%

EPS

$-0.35

Balance Sheet

Current Ratio

2.83

Quick Ratio

1.16

Debt/Equity

0.38

Other

Beta (Volatility)

0.77

Does ULBI Have a Competitive Moat?

Sign in to unlock

Moat Rating

🛡️ Narrow

Moat Trend

Stable

Moat Sources

3 Identified

Intangible Assets/IPSwitching CostsCost Advantages

The moat persists due to the specialized nature of its products for defense and industrial applications, which often have high barriers to entry, lengthy qualification processes, and critical performance requirements that favor incumbent, proven suppliers.

Moat Erosion Risks

  • Technological obsolescence if competitors develop superior or significantly cheaper specialized solutions.
  • Consolidation among key defense contractors could impact customer relationships and bargaining power.
  • Fluctuations in defense budgets or industrial capital expenditure impacting demand for niche products.

ULBI Competitive Moat Analysis

Sign up to see competitive advantages

ULBI Market Intelligence

Sentiment & Insider Activity

Social Sentiment

Neutral, likely low discussion given the small market cap and niche focus.

Institutional Sentiment

Neutral, with 30.7% institutional ownership but no recent analyst upgrades/downgrades or specific reports indicating shifting sentiment.

Insider Activity (Form 4)

No Form 4 filings reported in the last 90 days. Insiders hold a substantial 42% of shares, indicating long-term conviction but no recent buying signals.

Options Flow

Normal options activity; no specific data suggesting unusual institutional positioning.

Earnings Intelligence

Next Earnings

2026-05-08

Surprise Probability

Medium-Low

Historical Earnings Pattern

Q4 2025 earnings resulted in a significant miss on both top and bottom lines, which could predispose the market to react negatively to any further disappointments.

Key Metrics to Watch

Q1 2026 Revenue (consensus: $52.4M)Q1 2026 EPS (consensus: $0.15)Net Margin trajectory (return to positive)Forward guidance for Q2 2026

Competitive Position

Top Competitor

While direct like-for-like publicly traded competitors are hard to pinpoint, companies like EnerSys (ENS) in industrial batteries or specialized defense contractors like Kratos Defense & Security Solutions (KTOS) in communications represent segments of their market.

Market Share Trend

Stable in its niche markets; no specific data indicating significant gains or losses.

Valuation vs Peers

Trading at a significant discount based on traditional P/E multiples due to recent negative earnings. P/S ratio (around 0.57x based on projected run-rate) is low, suggesting potential undervaluation if profitability can be restored, but appropriate for a struggling growth company.

Competitive Advantages

  • Specialized battery and power solutions tailored for demanding defense and industrial applications.
  • Established customer relationships and lengthy product qualification processes creating high switching costs.
  • Proprietary technology and intellectual property in niche battery chemistries and communications systems.

Market Intelligence

Sign up free to unlock sentiment, earnings intel, and peer analysis

What Could Drive ULBI Stock Higher?

Near-Term (0-6 months)

  • Q1 2026 Earnings Report (May 8, 2026 before market open)
  • Potential new, significant defense contract announcement

Medium-Term (6-18 months)

  • Stabilization and improvement of net margins back to positive territory
  • Introduction of new high-performance battery or communications product lines

Long-Term (18+ months)

  • Increased defense spending leading to broader demand for specialized solutions
  • Technological advancements in battery chemistry enabling broader market adoption

Catalysts & Growth Drivers

Sign up free to see growth catalysts

What's the Bull Case for ULBI?

  • Consistent return to positive net margins and EPS beats in subsequent quarters.

  • Acceleration in organic revenue growth beyond incremental contract wins.

  • Strategic announcements of new product lines or significant market expansion efforts.

Bull Case Analysis

Sign up free to see the bull case

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

How Ultralife Corp Makes Money

Ultralife Corp designs, manufactures, and sells a range of advanced battery and power solutions, as well as communications and electronics systems. They serve highly specialized markets, primarily defense, aerospace, and industrial sectors, where reliability, performance, and specific form factors are critical. Their customers include government agencies and industrial partners who require robust and often custom-engineered power and communication solutions for demanding environments.

Read Full Business Model Breakdown

FAQ

What is the DVR Score for Ultralife Corp (ULBI)?

As of May 6, 2026, Ultralife Corp has a DVR Score of 0.4 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Ultralife Corp?

Ultralife Corp's market capitalization is approximately $113.8M..

What is the risk level for ULBI stock?

Our analysis rates Ultralife Corp's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of ULBI?

Ultralife Corp currently has a price-to-earnings (P/E) ratio of -19.1. This is below the market average, which could indicate the stock is undervalued or facing headwinds.

Is Ultralife Corp's revenue growing?

Ultralife Corp has reported revenue growth of 16.2%. The company is showing strong top-line momentum.

Is ULBI stock profitable?

Ultralife Corp has a profit margin of -3.1%. The company is currently unprofitable.

How often is the ULBI DVR analysis updated?

Our AI-powered analysis of Ultralife Corp is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on May 6, 2026.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for ULBI (Ultralife Corp) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

Navigated to ULBI Stock Risk & Deep Value Analysis